---
$id: https://graph.org.ai/products/commodity/51111750
$type: Product
source: UNSPSC
code: "51111750"
title: "Losoxantrone"
class: "51111700"
classTitle: "Antineoplastic antibiotics"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Losoxantrone

**UNSPSC Code**: 51111750
**Class**: [Antineoplastic antibiotics](Antineoplastic antibiotics.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anthrapyrazole antibiotic with the molecular formula C22H27N5O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 47KPH00809, chemically known as anthra(1,9-cd)pyrazol-6(2h)-one, 7-hydroxy-2-(2-((2-hydroxyethyl)amino)ethyl)-5-((2-((2-hydroxyethyl)amino)ethyl)amino)- but generally known as losoxantrone, which bears US NIH Compound Identifier 72116. European Medicines Agency schedules Losoxantrone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08597MIG. The term LOSOXANTRONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 7, No3, 1993, List 33). LOSOXANTRONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule losoxantrone under HS 29339990 and SITC 51577. As of Q4 2014, LOSOXANTRONE remains the US FDA Preferred Term for this commodity. Losoxantrone bears US NLM identifiers UMLS ID C0245032 and NCI Concept Code C1521. SMILES: O=C1C2C3C(N(NC3C3C1C(O)CCC3)CCNCCO)CCC2NCCNCCO.

